$HCIL
Hongchang International Co., Ltd Stock $hcil

$hcil Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000121390023022296 Filed on March 23, 2023

Income Statement

Concept	2022 Q4	2022	2021
Revenue	$49.99K	$78.95K	$96.48K
YoY Change	176.49%	-18.17%	-56.68%
Cost Of Revenue	$17.76K	$27.39K	$30.32K
YoY Change	184.16%	-9.68%	-74.42%
Gross Profit	$32.23K	$51.57K	$66.16K
YoY Change	172.44%	-22.06%	-36.49%
Gross Profit Margin	64.47%	65.31%	68.57%
Selling, General & Admin	$153.5K	$317.4K	$229.0K
YoY Change	353.05%	38.58%	-40.2%
% of Gross Profit	476.39%	615.4%	346.13%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$92.37K
YoY Change
% of Gross Profit		179.12%
Operating Expenses	$153.5K	$317.3K	$229.0K
YoY Change	353.19%	38.59%	-40.2%
Operating Profit	-$121.3K	-$265.8K	-$162.8K
YoY Change	450.16%	63.22%	-41.59%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$110.00	$200.00	-$180.00
YoY Change	-466.67%	-211.11%	200.0%
Pretax Income	-$121.2K	-$265.6K	-$163.0K
YoY Change	448.91%	62.91%	-78.35%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$121.2K	-$265.6K	-$163.0K
YoY Change	448.91%	62.91%	-70.27%
Net Earnings / Revenue	-242.45%	-336.38%	-168.97%
Basic Earnings Per Share		$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	-$157.90
COMMON SHARES
Basic Shares Outstanding		1.032B shares	1.032B shares
Diluted Shares Outstanding		1.032B shares	1.032B shares

Balance Sheet

Concept	2022 Q4	2022	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.43K	$11.43K	$4.320K
YoY Change		164.58%	-21.31%
Cash & Equivalents	$11.43K	$11.43K	$4.320K
Short-Term Investments
Other Short-Term Assets	$3.130K	$3.130K	$3.450K
YoY Change		-9.28%	4.23%
Inventory			$0.00
Prepaid Expenses
Receivables			$0.00
Other Receivables	$17.85K		$29.61K
Total Short-Term Assets	$32.40K	$32.40K	$37.38K
YoY Change	-13.3%	-13.32%	-37.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$0.00	$0.00	$56.17K
YoY Change		-100.0%	-58.18%
Goodwill
YoY Change
Intangibles	$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$0.00	$56.17K
YoY Change		-100.0%	-58.18%
TOTAL ASSETS
Total Short-Term Assets	$32.40K	$32.40K	$37.38K
Total Long-Term Assets		$0.00	$56.17K
Total Assets	$32.40K	$32.40K	$93.55K
YoY Change	-65.36%	-65.37%	-51.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.15K	$16.15K	$17.36K
YoY Change	-6.95%	-6.97%	-2.85%
Accrued Expenses	$285.1K	$155.1K	$224.4K
YoY Change	0.43%	-30.89%	12.6%
Deferred Revenue	$434.9K
YoY Change	-7.82%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.005M	$2.005M	$1.903M
YoY Change	5.34%	5.34%	8.02%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities			$0.00
YoY Change			-100.0%
Total Long-Term Liabilities		$0.00	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.005M	$2.005M	$1.903M
Total Long-Term Liabilities		$0.00	$0.00
Total Liabilities	$2.005M	$1.790M	$1.709M
YoY Change	5.34%	4.74%	7.48%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.89M
YoY Change	1.35%
Common Stock	$1.032M
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.757M	-$1.757M	-$1.615M
YoY Change
Total Liabilities & Shareholders Equity	$32.40K	$32.40K	$93.55K
YoY Change	-65.36%	-65.37%	-51.85%

Cashflow Statement

Concept	2022 Q4	2022	2021
OPERATING ACTIVITIES
Net Income	-$121.2K	-$265.6K	-$163.0K
YoY Change	448.91%	62.91%	-70.27%
Depreciation, Depletion And Amortization		$92.37K
YoY Change
Cash From Operating Activities	-$187.9K	-$292.3K	-$141.1K
YoY Change	676.29%	107.1%	545.95%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	192.4K	$196.5K	162.4K
YoY Change	344.01%	20.96%	362.18%
NET CHANGE
Cash From Operating Activities	-187.9K	-$292.3K	-141.1K
Cash From Investing Activities	0.000	0.000
Cash From Financing Activities	192.4K	$196.5K	162.4K
Net Change In Cash	4.450K	$7.105K	$0.00
YoY Change	-76.73%
FREE CASH FLOW
Cash From Operating Activities	-$187.9K	-$292.3K	-$141.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-26731
CY2022	dei	Entity Registrant Name EntityRegistrantName	HEYU BIOLOGICAL TECHNOLOGY CORPORATION
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0627910
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	Room 903&904
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Huli Building
CY2022	dei	Entity Address Address Line3 EntityAddressAddressLine3	619 Sishui Street
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Xiamen City
CY2022	dei	Entity Address Country EntityAddressCountry	CN
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	361009
CY2022	dei	City Area Code CityAreaCode	(86)
CY2022	dei	Local Phone Number LocalPhoneNumber	158 5924 0902
CY2022	dei	Security12b Title Security12bTitle	None
CY2022	dei	Trading Symbol TradingSymbol	None
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	1961685.4	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1032466000	shares
CY2022	dei	Auditor Name AuditorName	WWC, P.C.
CY2022	dei	Auditor Firm AuditorFirmId	1171
CY2022	dei	Auditor Location AuditorLocation	San Mateo, California
CY2022Q4	us-gaap	Cash Cash	11428	usd
CY2021Q4	us-gaap	Cash Cash	4323	usd
CY2022Q4	hybt	Other Receivables Net OtherReceivablesNet	17845	usd
CY2021Q4	hybt	Other Receivables Net OtherReceivablesNet	29608	usd
CY2022Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	3131	usd
CY2021Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	3446	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	32404	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	37377	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	56172	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	56172	usd
CY2022Q4	us-gaap	Assets Assets	32404	usd
CY2021Q4	us-gaap	Assets Assets	93549	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16150	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	17356	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	285081	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	283874	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	434890	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	471788	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	140	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	17	usd
CY2021Q4	hybt	Operating Lease Liability Current Portion OperatingLeaseLiabilityCurrentPortion	58073	usd
CY2022Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	1268749	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	1072293	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2005010	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1903401	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2005010	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1903401	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1032466000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1032466000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1032466000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1032466000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1032466	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1032466	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17149050	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17149050	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-52298	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-175659	usd
CY2022Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	-19886700	usd
CY2021Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	-19621121	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1757482	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1615264	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-215124	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	-194588	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1972606	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1809852	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32404	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	93549	usd
CY2022	us-gaap	Revenues Revenues	78953	usd
CY2021	us-gaap	Revenues Revenues	96478	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	27385	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	30315	usd
CY2022	us-gaap	Gross Profit GrossProfit	51568	usd
CY2021	us-gaap	Gross Profit GrossProfit	66163	usd
CY2022	hybt	Selling Expenses SellingExpenses	404	usd
CY2021	hybt	Selling Expenses SellingExpenses	1284	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	316943	usd
CY2021	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	227715	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	317347	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	228999	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-265779	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-162836	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	200	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-184	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-265579	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-163020	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-265579	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-163020	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-265579	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-163020	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-89290	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	90821	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-176289	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-253841	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-34071	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-34195	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-142218	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-219646	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1032466000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1032466000	shares
CY2022	us-gaap	Profit Loss ProfitLoss	-265579	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-163020	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1317	usd
CY2022	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	5115	usd
CY2021	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-20205	usd
CY2021	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	101	usd
CY2022	hybt	Increase Decrease Operating Lease Rightofuse Asset IncreaseDecreaseOperatingLeaseRightofuseAsset	-56172	usd
CY2021	hybt	Increase Decrease Operating Lease Rightofuse Asset IncreaseDecreaseOperatingLeaseRightofuseAsset	-78143	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	15986	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-515	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1207	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-10359	usd
CY2022	hybt	Advances From Customer AdvancesFromCustomer	36898	usd
CY2021	hybt	Advances From Customer AdvancesFromCustomer	-12205	usd
CY2022	hybt	Increase Decrease Lease Liability IncreaseDecreaseLeaseLiability	58073	usd
CY2021	hybt	Increase Decrease Lease Liability IncreaseDecreaseLeaseLiability	79019	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-292300	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-141144	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	330598	usd
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	162410	usd
CY2022	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	134141	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	196457	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	162410	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	102948	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-22432	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7105	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1166	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4323	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5489	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11428	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4323	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1624401	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-22431	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-163020	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1809852	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1809852	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	102825	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-265579	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1972606	usd
CY2019Q1	hybt	Equity Interests EquityInterests	0.90	pure
CY2020Q1	hybt	Gross Proceeds Percentage GrossProceedsPercentage	0.02	pure
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Management believes that the estimates used in preparing the financial statements are reasonable and prudent; however, actual results could differ from these estimates. Significant estimates include the allowance for doubtful accounts, impairment assessments of goodwill, valuation of deferred tax assets, rebilling collections and certain accrued liabilities such as contingent liabilities. As of December 31, 2022, the Company considered the economic implications of the COVID-19 pandemic on its significant judgments and estimates. Given the impact and other unforeseen effects on the global economy from the COVID-19 pandemic, these estimates required increased judgment, and actual results could differ from these estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2019Q3	hybt	Operating Lease Right Of Uses Asset OperatingLeaseRightOfUsesAsset	215298	usd
CY2019Q3	hybt	Office Space Lease OfficeSpaceLease	215298	usd
CY2022Q4	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	6.8983	pure
CY2021Q4	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	6.3588	pure
CY2022Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	2000000000	shares
CY2021Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	2000000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	hybt	Number Of Shares Issued And Outstanding NumberOfSharesIssuedAndOutstanding	1032466000	shares
CY2021Q4	hybt	Number Of Shares Issued And Outstanding NumberOfSharesIssuedAndOutstanding	1032466000	shares
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-265579	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-163020	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1032466000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1032466000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022Q4	hybt	Retained Earning Accumulated Deficit RetainedEarningAccumulatedDeficit	19886700	usd
CY2022Q4	hybt	Working Capital Deficit WorkingCapitalDeficit	1972606	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11428	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4323	usd
CY2022Q4	us-gaap	Deposits Deposits	13954	usd
CY2021Q4	us-gaap	Deposits Deposits	15603	usd
CY2022Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	3891	usd
CY2021Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	14005	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	17845	usd
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	29608	usd
CY2022	hybt	Schedule Of Advances To Suppliers Table Text Black ScheduleOfAdvancesToSuppliersTableTextBlack	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Purchases of scientific research equipment</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">3,131</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">3,446</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,131</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,446</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table>
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	3131	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	3446	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	3131	usd
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	3446	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	56172	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	434890	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	471788	usd
CY2019Q4	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	5.5	cny
CY2019Q3	hybt	Total Preordering Payment Amount TotalPreorderingPaymentAmount	1.5	usd
CY2019Q3	hybt	Total Preordering Payment Amount TotalPreorderingPaymentAmount	1.5	usd
CY2022	us-gaap	Line Of Credit Facility Periodic Payment LineOfCreditFacilityPeriodicPayment	2.5	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	155078	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	166337	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	130003	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	117537	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	285081	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	283874	usd
CY2022Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	1268749	usd
CY2021Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	1072293	usd
CY2022	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	78593	usd
CY2021	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	96478	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent		usd
CY2022Q4	hybt	Operating Lease Liability Current Portion OperatingLeaseLiabilityCurrentPortion		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1032466000	shares
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2022	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies		usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent		usd
CY2021Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent		usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001086303

Files In Submission

Name	View Source	Status
0001213900-23-022296-index-headers.html	Edgar Link	pending
0001213900-23-022296-index.html	Edgar Link	pending
0001213900-23-022296.txt	Edgar Link	pending
0001213900-23-022296-xbrl.zip	Edgar Link	pending
f10k2022ex31-1_heyubio.htm	Edgar Link	pending
f10k2022ex31-2_heyubio.htm	Edgar Link	pending
f10k2022ex32-1_heyubio.htm	Edgar Link	pending
f10k2022ex32-2_heyubio.htm	Edgar Link	pending
f10k2022ex4-1_heyubio.htm	Edgar Link	pending
f10k2022_heyubiological.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hybt-20221231.xsd	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
hybt-20221231_def.xml	Edgar Link	unprocessable
hybt-20221231_cal.xml	Edgar Link	unprocessable
hybt-20221231_lab.xml	Edgar Link	unprocessable
f10k2022_heyubiological_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hybt-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HCIL
Hongchang International Co., Ltd Stock $hcil

2022 Q4 Form 10-K Financial Statement

#000121390023022296 Filed on March 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCIL Hongchang International Co., Ltd Stock $hcil

2022 Q4 Form 10-K Financial Statement

#000121390023022296 Filed on March 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCIL
Hongchang International Co., Ltd Stock $hcil